Search Results 1-10 of 17349 for Proto-oncogene
The Department of Cancer Biology at Mayo Clinic is studying oncogenic gene dysregulation and carcinogenesis, including the cancer signaling process.
JACKSONVILLE, Fla. — Researchers at Mayo Clinic have identified a genetic promoter of cancer that drives a major form of lung cancer.
During these experiences, the fellow: Learns to recognize endocrine cytology and pathology; Interprets technology — immunostains, RET proto-oncogene, DNA ploidy ...
GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms. Blood ... Oncogenic N-Ras and Tet2 haploinsufficiency collaborate to dysregulate ...
Bidirectional sequence analysis was performed to test for the presence of a mutation in exons 10, 11, 13, 14, 15 and 16 of the RET proto-oncogene and was ...
... proto-oncogene 1 (ROS1) genomic alterations. * Has no known tumour genomic alterations in neurotrophic tyrosine receptor kinase (NTRK), proto-oncogene B-raf ...
While PKD1 mediates cell proliferation and also acts as a suppressor of breast tumor cell invasion, PKD3, when expressed, mediates all oncogenic functions.
These cancer-causing genes can take on three different forms. Oncogenes act like the accelerator of the car: mutations in these genes put the pedal to the metal ...
The study, published in the Sept. 10 issue of Cancer Cell, overturns the current belief that a mutation in the KRAS oncogene is enough to initiate pancreatic ...
The precision medicine study appears online in Oncogene and focuses on kidney cancer and its metastases. Recent studies of the same epigenomic fingerprint ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift doubles in impact to help more patients.